. | MR stable (n = 197) . | MR improvement (n = 100) . | MR worsening (n = 32) . | P value . |
---|---|---|---|---|
Death | 27 (13.7%) | 13 (13.0%) | 5 (15.6%) | 0.940 |
. | MR stable (n = 197) . | MR improvement (n = 100) . | MR worsening (n = 32) . | P value . |
---|---|---|---|---|
Death | 27 (13.7%) | 13 (13.0%) | 5 (15.6%) | 0.940 |
. | None-to-mild MR (n = 251) . | Moderate MR (n = 65) . | Moderate-to-severe/severe MR (n = 13) . | P value . |
---|---|---|---|---|
Death | 33 (13.2%) | 7 (10.8%) | 5 (38.5%) | 0.044 |
. | None-to-mild MR (n = 251) . | Moderate MR (n = 65) . | Moderate-to-severe/severe MR (n = 13) . | P value . |
---|---|---|---|---|
Death | 33 (13.2%) | 7 (10.8%) | 5 (38.5%) | 0.044 |
Bold values denote statistical significance at the p < 0.05 level.
Abbreviations: MR, mitral regurgitation; TTVI, transcatheter tricuspid valve interventions.
. | MR stable (n = 197) . | MR improvement (n = 100) . | MR worsening (n = 32) . | P value . |
---|---|---|---|---|
Death | 27 (13.7%) | 13 (13.0%) | 5 (15.6%) | 0.940 |
. | MR stable (n = 197) . | MR improvement (n = 100) . | MR worsening (n = 32) . | P value . |
---|---|---|---|---|
Death | 27 (13.7%) | 13 (13.0%) | 5 (15.6%) | 0.940 |
. | None-to-mild MR (n = 251) . | Moderate MR (n = 65) . | Moderate-to-severe/severe MR (n = 13) . | P value . |
---|---|---|---|---|
Death | 33 (13.2%) | 7 (10.8%) | 5 (38.5%) | 0.044 |
. | None-to-mild MR (n = 251) . | Moderate MR (n = 65) . | Moderate-to-severe/severe MR (n = 13) . | P value . |
---|---|---|---|---|
Death | 33 (13.2%) | 7 (10.8%) | 5 (38.5%) | 0.044 |
Bold values denote statistical significance at the p < 0.05 level.
Abbreviations: MR, mitral regurgitation; TTVI, transcatheter tricuspid valve interventions.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.